Literature DB >> 11265173

Primary pulmonary hypertension: the pressure rises for a gene.

J R Thomson1, R C Trembath.   

Abstract

Primary pulmonary hypertension (PPH) represents the end stage of a disruption of pulmonary vascular integrity, of unknown cause. Although PPH is associated with several systemic disorders, there have hitherto been few clues as to the aetiological factors responsible for the pathogenesis of this condition. As an example of the application of modern molecular genetics and positional cloning, this leader describes the range of studies currently under way, which aim to find the gene that underlies PPH, and summarises the implications of the identification of such a gene.

Entities:  

Mesh:

Year:  2000        PMID: 11265173      PMCID: PMC1731125          DOI: 10.1136/jcp.53.12.899

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

Review 1.  The intima: development and monoclonal responses to injury.

Authors:  S M Schwartz; M W Majesky; C E Murry
Journal:  Atherosclerosis       Date:  1995-12       Impact factor: 5.162

Review 2.  Cellular and molecular mechanisms of pulmonary vascular remodeling.

Authors:  K R Stenmark; R P Mecham
Journal:  Annu Rev Physiol       Date:  1997       Impact factor: 19.318

Review 3.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

4.  Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32.

Authors:  W C Nichols; D L Koller; B Slovis; T Foroud; V H Terry; N D Arnold; D R Siemieniak; L Wheeler; J A Phillips; J H Newman; P M Conneally; D Ginsburg; J E Loyd
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

5.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

6.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

7.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

8.  Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.

Authors:  T W Higenbottam; D Spiegelhalter; J P Scott; V Fuster; A T Dinh-Xuan; N Caine; J Wallwork
Journal:  Br Heart J       Date:  1993-10

9.  Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta.

Authors:  M D Botney; L Bahadori; L I Gold
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Primary pulmonary hypertension and fenfluramine use.

Authors:  F Brenot; P Herve; P Petitpretz; F Parent; P Duroux; G Simonneau
Journal:  Br Heart J       Date:  1993-12
View more
  2 in total

Review 1.  Pulmonary arterial hypertension: new ideas and perspectives.

Authors:  N Galiè; A Torbicki
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Authors:  R D Machado; M W Pauciulo; J R Thomson; K B Lane; N V Morgan; L Wheeler; J A Phillips; J Newman; D Williams; N Galiè; A Manes; K McNeil; M Yacoub; G Mikhail; P Rogers; P Corris; M Humbert; D Donnai; G Martensson; L Tranebjaerg; J E Loyd; R C Trembath; W C Nichols
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.